Actionable and Equitable Testing with NxGen MDx

NxGen MDx is a medical laboratory dedicated to providing high-quality genetic screening and pathogen testing. We ensure that patients everywhere have access to equitable screens and tests that can improve their reproductive and overall health.

Help Your Patients Achieve Their Reproductive Goals

NatalCare is NxGen MDx’s curation philosophy which focuses on providing better pregnancy and newborn outcomes. Our screens and tests follow evidence-based, medical societal guidelines and offer actionable results and equitable care for all patients.

Carrier Screening

  • NxGen MDx's intelligently curated Super Panel carrier screen is ethnicity-neutral and focuses on clinical actionability for every patient.
  • Allows couples at risk of passing along a genetic condition to pursue timely and appropriate management or treatment options before or during pregnancy.


“Carrier screening paradigms should be ethnic and population neutral and more inclusive of diverse populations to promote equity and inclusion."
-The American College of Medical Genetics and Genomics1

Carrier Screening

Non-Invasive Prenatal Screening (NIPS)

  • Whole-genome sequencing provides results to 99.7% of patients using NxGen MDx’s NIPS.
  • NxGen MDx’s NIPS is appropriate for all pregnancies, regardless of age, ethnicity, BMI, or use of assisted reproductive technology.

"Cell-free DNA is the most sensitive and specific screening test for common fetal aneuploidies”
-The American College of Obstetricians and Gynecologists2

Non-Invasive Prenatal Screening (NIPS)

Hereditary Cancer Testing

  • NxGen MDx’s Hereditary Cancer Panel analyzes 32 genes recommended by the National Comprehensive Cancer Network (NCCN).
  • Our streamlined support includes pre- and post-test genetic counseling and electronic tools to identify at-risk individuals.

"A hereditary cancer risk assessment is the key to identifying patients and families who may be at increased risk of developing certain types of cancer. Assessments should be performed by obstetrician–gynecologists or other obstetric–gynecologic care providers and should be updated regularly."
-The American College of Obstetricians and Gynecologists3

Hereditary Cancer Testing

Preimplantation Genetic Testing

  • Industry-leading, high-resolution sequencing for results you can trust.
  • NxGen MDx's innovative bioinformatics pipeline is designed to reduce false positives and increase the number of transferable embryos.

"When comparing PGT-A to non-PGT-A fresh and frozen embryo transfers, PGT-A embryo transfers have a significantly higher live birth rate."
-Reproductive BioMedicine Online4

Preimplantation Genetic Testing

Urinary Tract Infection (UTI) Testing

  • Comprehensive PCR testing for UTIs that provides detailed information necessary for effective treatment.
  • Receive results and information about antibiotic resistance in just 24 hours from sample receipt.


"All pregnant women should be screened for bacteriuria… as it is an important risk factor for pyelonephritis in this population."5

Urinary Tract Infection (UTI) Testing

Vaginitis Testing

  • Comprehensive PCR testing for vaginitis that provides detailed information necessary for effective treatment.
  • Receive results and information about antibiotic resistance in just 24 hours from sample receipt.


"STDs can complicate pregnancy and may have serious consequences for both a woman and her developing baby."
-Centers for Disease Control and Prevention6

Vaginitis Testing

Respiratory Pathogens Testing

  • Comprehensive PCR testing that is 10 times more likely to provide a positive result than a COVID-19 test alone.
  • Options for COVID and COVID/flu PCR testing as well as a comprehensive panel that tests for pathogens causing 99% of upper and lower respiratory infections.


"SARS-CoV-2 infection can present with a broad clinical differential that includes many other respiratory viruses; therefore, accurate tests are crucial to distinguish true COVID-19 cases from pathogens that do not require urgent public health interventions."
-Virology Journal7

Respiratory Pathogens Testing

Interested in Learning More about One of Our Products?

Fill out the form below, and we will reach out to you shortly.

Interested in Learning More about One of Our Products?
  1. Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Oct;23(10):1793–806.
  2. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020 Oct;136(4):e48-e69. doi: 10.1097/AOG.0000000000004084. PMID: 32804883.
  3. Hereditary cancer syndromes and risk assessment. ACOG Committee Opinion No. 793. American College of Obstetricians and Gynecologists. Obstet Gynecol 2019;134:e143–9.
  4. Sadecki E, Rust L, Walker DL, Fredrickson JR, Krenik A, Kim T, et al. Comparison of live birth rates after IVF–embryo transfer with and without preimplantation genetic testing for aneuploidies. Reproductive BioMedicine Online. 2021 Dec 1;43(6):995–1001.
  5. Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015 Mar 16;11(1):67–77.
  6. STD Facts - STDs & Pregnancy Detailed Fact Sheet [Internet]. 2021 [cited 2022 Apr 7]. Available from: https://www.cdc.gov/std/pregnancy/stdfact-pregnancy-detailed.htm
  7. Marshall NC, Kariyawasam RM, Zelyas N, Kanji JN, Diggle MA. Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic. Virology Journal. 2021 May 1;18(1):93.